These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38559420)

  • 1. Preventative effects of dapagliflozin on early ventricular dysfunction and remodeling in patients with acute anterior STEMI - The PREDOMINACE trial.
    Liu X; Zhang S; Chen K; Che J; Li C
    Am Heart J Plus; 2022 Jun; 18():100181. PubMed ID: 38559420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Compound Danshen Dripping Pills on Ventricular Remodeling and Cardiac Function after Acute Anterior Wall ST-Segment Elevation Myocardial Infarction (CODE-AAMI): Protocol for a Randomized Placebo-Controlled Trial.
    Wu YJ; Deng B; Wang SB; Qiao R; Zhang XW; Lu Y; Wang L; Gu SZ; Zhang YQ; Li KQ; Yu ZL; Wu LX; Zhao SB; Zhou SL; Yang Y; Wang LS
    Chin J Integr Med; 2023 Dec; 29(12):1059-1065. PubMed ID: 37656413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dapagliflozin improves myocardial flow reserve in patients with type 2 diabetes: the DAPAHEART Trial: a preliminary report.
    Leccisotti L; Cinti F; Sorice GP; D'Amario D; Lorusso M; Guzzardi MA; Mezza T; Gugliandolo S; Cocchi C; Capece U; Indovina L; Ferraro PM; Iozzo P; Crea F; Giordano A; Giaccari A
    Cardiovasc Diabetol; 2022 Sep; 21(1):173. PubMed ID: 36057768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing the efficacy of angiotensin receptor-neprilysin inhibitor and enalapril in acute anterior STEMI patients after primary percutaneous coronary intervention: a prospective randomized trial.
    Dong Y; Xu Y; Ding C; Yu Z; Yu Z; Xia X; Chen Y; Jiang X
    Cardiovasc Diagn Ther; 2022 Feb; 12(1):42-54. PubMed ID: 35282662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of dapagliflozin on cardiac function following anterior myocardial infarction in non-diabetic patients - DACAMI (a randomized controlled clinical trial).
    Dayem KA; Younis O; Zarif B; Attia S; AbdelSalam A
    Int J Cardiol; 2023 May; 379():9-14. PubMed ID: 36889650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventive Effect Observation of Dapagliflozin on Middle and Later Ventricular Remodeling in Patients with Acute ST Segment Elevation Anterior Wall Myocardial Infarction: A Single-Center, Retrospective Cohort Study.
    Liu Z; Liu L; Zhang H; Jiang Y; Wang H
    J Healthc Eng; 2022; 2022():3955914. PubMed ID: 35463678
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of Sodium-Glucose Cotransporter-2 Inhibitors in Clinical Practice for Heart Failure Prevention and Treatment: Beyond Type 2 Diabetes. A Narrative Review.
    Rao S
    Adv Ther; 2022 Feb; 39(2):845-861. PubMed ID: 34881413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of comprehensive remote ischemic conditioning in anterior ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: Design and rationale of the CORIC-MI randomized trial.
    Song L; Yan H; Zhou P; Zhao H; Liu C; Sheng Z; Tan Y; Yi C; Li J; Zhou J
    Clin Cardiol; 2018 Aug; 41(8):997-1003. PubMed ID: 29726013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of early PCSK9 inhibitor treatment on heart after percutaneous coronary intervention in patients with STEMI: Design and rationale of the PERFECT II trial.
    Xia J; Wang X; Zhou J; Wang D; Pang Y; Xu X; Sang Z; Zhang Y; Zhang J; Wu S; Xiao Z; Hou L
    Front Cardiovasc Med; 2022; 9():1009674. PubMed ID: 36211588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Home-Based Baduanjin Exercise on Left Ventricular Remodeling in Patients With Acute Anterior ST-Segment Elevation Myocardial Infarction: Study Protocol for a Randomized Controlled Trial.
    Cai Y; Kang L; Li H; Luo Y; Wen J; Gong Z; Chu Q; Qiu Y; Luo C; Chen K; Zhao X; Li R
    Front Cardiovasc Med; 2022; 9():778583. PubMed ID: 35224034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remote ischemic post-conditioning of the lower limb during primary percutaneous coronary intervention safely reduces enzymatic infarct size in anterior myocardial infarction: a randomized controlled trial.
    Crimi G; Pica S; Raineri C; Bramucci E; De Ferrari GM; Klersy C; Ferlini M; Marinoni B; Repetto A; Romeo M; Rosti V; Massa M; Raisaro A; Leonardi S; Rubartelli P; Oltrona Visconti L; Ferrario M
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1055-63. PubMed ID: 24156966
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Yoshihara F; Imazu M; Sakuma I; Hiroi Y; Hara H; Okazaki O; Ishiguro C; Izumi C; Noguchi T; Shiraiwa T; Nishioka N; Fujii K; Iwakura K; Tomonaga O; Kobayashi K; Takihata M; Yumoto K; Takase H; Himi T; Shimizu I; Murakami T; Wagatsuma K; Sato K; Hiramatsu T; Akabame S; Hata S; Asakura M; Kawabata T; Omae K; Ito S; Kitakaze M;
    EClinicalMedicine; 2023 Dec; 66():102334. PubMed ID: 38192595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term efficacy of angiotensin receptor-neprilysin inhibitor treatment in patients with ST-segment elevation myocardial infarction with reduced ejection fraction after primary percutaneous coronary intervention: a propensity score matching study.
    Zhang Q; Qiao B; Han Y; Sun S; Wang B; Wei S
    BMC Cardiovasc Disord; 2022 Nov; 22(1):463. PubMed ID: 36333668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).
    Pu J; Ding S; Ge H; Han Y; Guo J; Lin R; Su X; Zhang H; Chen L; He B;
    Circulation; 2017 Oct; 136(16):1462-1473. PubMed ID: 28844990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of the ischemic post-conditioning on the prevention of the cardio-renal damage in patients with acute ST-segment elevation myocardial infarction after primary percutaneous coronary intervention].
    Wang YY; Li T; Liu YW; Liu BJ; Hu XM; Wang Y; Gao WQ; Wu P; Huang L; Li X; Peng WJ; Ning M
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Apr; 45(4):277-282. PubMed ID: 28545277
    [No Abstract]   [Full Text] [Related]  

  • 16. Rationale and design of the Biventricular Evaluation of Gliflozins effects In chroNic Heart Failure: BEGIN-HF study.
    Correale M; Antohi EL; Inciardi RM; Mazzeo P; Coiro S; Ishihara S; Petroni R; Monitillo F; Leone M; Triggiani M; Sarwar CMS; Dungen HD; Talha KM; Brunetti ND; Butler J; Nodari S;
    ESC Heart Fail; 2023 Jun; 10(3):2066-2073. PubMed ID: 36924023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influencing factors and prognostic value of left ventricular systolic dysfunction in patients with complete occlusion of the left anterior descending artery reperfused by primary percutaneous coronary intervention.
    Jing Y; Lu C; Guo S; Chen B; Ye X; He Q; Xia W; Xin T
    BMC Cardiovasc Disord; 2023 Jul; 23(1):344. PubMed ID: 37430213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Randomized, double-blind, dose ranging clinical trial of intravenous FDY-5301 in acute STEMI patients undergoing primary PCI.
    Adlam D; Zarebinski M; Uren NG; Ptaszynski P; Oldroyd KG; Munir S; Zaman A; Contractor H; Kiss RG; Édes I; Szachniewicz J; Nagy GG; Garcia MJ; Tomcsanyi J; Irving J; Sharp ASP; Musialek P; Lupkovics G; Shirodaria C; Selvanayagam JB; Quinn P; Ng L; Roth M; Insko MA; Haber B; Hill S; Siegel L; Tulloch S; Channon KM
    Int J Cardiol; 2022 Jan; 347():1-7. PubMed ID: 34774885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GLP-1 receptor agonists-SGLT-2 inhibitors combination therapy and cardiovascular events after acute myocardial infarction: an observational study in patients with type 2 diabetes.
    Marfella R; Prattichizzo F; Sardu C; Rambaldi PF; Fumagalli C; Marfella LV; La Grotta R; Frigé C; Pellegrini V; D'Andrea D; Cesaro A; Calabrò P; Pizzi C; Antonicelli R; Ceriello A; Mauro C; Paolisso G
    Cardiovasc Diabetol; 2024 Jan; 23(1):10. PubMed ID: 38184582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colchicine for Left Ventricular Infarct Size Reduction in Acute Myocardial Infarction: A Phase II, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Protocol - The COVERT-MI Study.
    Bresson D; Roubille F; Prieur C; Biere L; Ivanes F; Bouleti C; Dubreuil O; Rioufol G; Boutitie F; Sideris G; Elbaz M; Bochaton T; De Bourguignon C; El Jonhy N; Dufay N; Dhelens C; Croisille P; Prunier F; Angoulvant D; Ovize M; Maucort-Boulch D; Mewton N
    Cardiology; 2021; 146(2):151-160. PubMed ID: 33582664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.